The evolutionary dynamics of extrachromosomal DNA in human cancers

Joshua T Lange1,2, John C Rose3, Celine Y Chen4

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Nature Genetics
|September 19, 2022
PubMed

Insights

Extrachromosomal DNA (ecDNA) amplification drives aggressive cancers. Random ecDNA inheritance creates significant tumor cell variation, enabling rapid adaptation and predicting poor patient outcomes.

Area of Science:

  • Cancer Biology
  • Genetics
  • Molecular Oncology

Background:

  • Oncogene amplification on extrachromosomal DNA (ecDNA) is a frequent driver of aggressive tumors, leading to drug resistance and reduced survival.
  • The mechanisms of nonchromosomal oncogene inheritance and their influence on somatic variation and selection within tumors remain poorly understood.

Purpose of the Study:

  • To investigate the impact of random ecDNA inheritance on intratumoral heterogeneity and cancer cell adaptation.
  • To elucidate how ecDNA dynamics contribute to aggressive cancer phenotypes and patient outcomes.

Main Methods:

  • Integration of theoretical models for random segregation.
  • Unbiased image analysis of ecDNA.
  • CRISPR-based ecDNA tagging combined with live-cell imaging and CRISPR-C.

Main Results:

  • Demonstrated that random ecDNA inheritance leads to extensive intratumoral ecDNA copy number heterogeneity.
  • Showcased rapid adaptation of cancer cells to metabolic stress and targeted therapies.
  • Observed that ecDNAs enhance host cell survival and can change within a single cell cycle.

Conclusions:

  • The random inheritance pattern of ecDNA significantly contributes to intratumoral heterogeneity and rapid adaptation in cancer.
  • ecDNA properties can predict aggressive cancer features and explain poor patient outcomes.
  • ecDNA facilitates rapid genomic adaptation, a mechanism distinct from chromosomal oncogene amplification.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.8K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.1K